Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

September 4-7, 2018
Hynes Convention Center,
Boston, MA

the largest bioprocessing event bringing you the science, technologies and partners needed to accelerate promising biologics towards commercial success

More science. More new data. More case studies. BPI has you covered.

Exhibit Hall Passes Now Available

Access the largest exhibition devoted exclusively to biopharmaceutical manufacturing by securing your exhibit hall pass today.

7 Tracks Cover the Entire BioProcessing Spectrum

[NEW FOR 2018] Speed from Gene to Market

Gain the industry insights you need to accelerate speed and compress timelines to IND and BLA submissions.

[NEW for 2018] Bioprocessing 4.0 - The Path to Smart Manufacturing

Apply today's data, analytics, automation and technology to transform biologics manufacturing by reducing costs and increasing efficiencies & throughput

Cell Culture & Upstream Processing

Accelerate your product from early stage development to commercial-scale manufacturing.

Recovery & Purification

Improve your downstream processes to reduce COGS.

Manufacturing Strategy

Reduce costs, increase manufacturing efficiency and remain flexible in your biomanufacturing operations.

Analytical & Quality

Ensure your products meet increasing analytical and quality regulations.

Drug Product, Fill-Finish & Formulations

Accelerate your drug substance towards a finished drug product.

New for BPI 2018

VISIONARY KEYNOTE LINEUP
  • Bob Langer, MIT
  • Tina Larson, Achaogen
  • Jason Walther, Sanofi
  • Thomas Seewoester, Amgen
  • Elsie DeBella, Momenta Pharmaceuticals
  • E. Morrey Atkinson, Bristol-Myers Squibb
  • Rebecca Sendak, Sanofi
TWO NEW CONFERENCE TRACKS
  • Speed from Gene to Market
  • Bioprocessing 4.0 – The Path to Smart Manufacturing
FIVE PRE-CONFERENCE SYMPOSIA
  • Viral Clearance
  • Process Intensification
  • Cell Line Development
  • PAT and Advanced Process Control
  • Continuous Processing
TECHNOLOGY AND INNOVATION ROUNDTABLE

Identify, evaluate and discuss today's emerging bioprocess technologies that can help accelerate biologics towards commercial success.

KEY UPDATES FROM BPOG
  • Technology Roadmap
  • Drug Product Robustness Studies
  • Real-Time Release
  • Disposables 5-Year Plan
CELL & GENE THERAPY BIOPROCESSING & COMMERCIALIZATION

Your registration to BPI 2018 includes access to our co-located Cell & Gene Therapy Bioprocessing & Commercialization meeting.



Advance Your Drug Candidates Closer to Approval

The Most Innovative Science

Capitalize on 225+ case studies and new data presentations from global thought leaders to improve integration, productivity and cost savings across the entire bioprocessing spectrum.

The Largest Exhibition Devoted to Biomanufacturing

Accelerate your drug product to market by accessing innovative products and technologies from 160+ global exhibitors devoted to serving the biopharmaceutical manufacturing industry.

The Right Partners for You

Establish successful partnerships with 2000+ bioprocessing professionals made up of global innovators, suppliers, academia and associations who can help you achieve commercial success for your novel therapeutics.

Present at Scientific Poster


Share your company's new research by presenting a poster at BPI 2018. All posters are displayed in the exhibit & poster hall area throughout the event.

Please note that all poster presenters must be registered attendees. The deadline to submit your abstract is August 3, 2018.

Cell & Gene Therapy Bioprocessing & Commercialization


Your registration to BPI includes complimentary access to all of the main conference sessions of our co-located Cell & Gene Therapy Bioprocessing & Commercialization meeting.

Register today and transform innovative research to drive the future of cell & gene therapy manufacturing and commercialization.

MassBio’s CRO/CMO Symposium


MassBio’s CRO/CMO Symposium has historically gathered over 300 attendees to discuss and evaluate the best practices in shortening time to market.   Through a series of conference-wide panel discussions and breakout sessions, we will evaluate the strategies that have evolved in outsourcing and strategic partnerships in pre-clinical, clinical and manufacturing, and commercialization.  Access to this symposium is included with your BPI main conference registration.

Sponsorship & Exhibition Opportunities


Highlight your company's expertise to a global audience of 2000+ bioprocessing scientists and decision makers.  A wide variety of options are available to accommodate your company's goals and budget.

Bioprocess Monitoring and Control Featured Report


The need for advanced control strategies for bioprocessing and biomanufacturing is growing, and several manufacturers already have leveraged new automation and software solutions for bioprocess monitoring and control. Authors discuss new approaches for process control that make use of increased computational power; advanced sensors, probes, and sampling technologies; and new software systems that can be applied to a wide range of operational modes (e.g., perfusion, continuous, and multicolumn platforms). Such technologies can be applied with single-use systems and within PAT and “machine learning” applications.